Understanding What Is the Life Expectancy of Someone With Nintedanib?
•
4 min read
In a pooled analysis of six clinical trials involving idiopathic pulmonary fibrosis (IPF) patients, exploratory survival data suggested a significant extension of life expectancy, with one model estimating mean survival at 11.6 years for those treated with nintedanib compared to 3.7 years for the placebo group.
